Ruo-kai Lin

Taipei, TNQ 11031, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Monitoring breast cancer progression through circulating methylated GCM2 and TMEM240 detection.

Monitoring breast cancer progression through circulating methylated GCM2 and TMEM240 detection.

Journal: Clinical epigenetics

Published: January 25, 2025

Hypermethylation of the Gene Body in SRCIN1 Is Involved in Breast Cancer Cell Proliferation and Is a Potential Blood-Based Biomarker for Early Detection and a Poor Prognosis.

Hypermethylation of the Gene Body in SRCIN1 Is Involved in Breast Cancer Cell Proliferation and Is a Potential Blood-Based Biomarker for Early Detection and a Poor Prognosis.

Journal: Biomolecules

Published: April 10, 2024

Machine learning approaches for predicting 5-year breast cancer survival: A multicenter study.

Machine learning approaches for predicting 5-year breast cancer survival: A multicenter study.

Journal: Cancer science

Published: March 15, 2023

Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer.

Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer.

Journal: Frontiers in oncology

Published: July 27, 2022

Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer.

Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer.

Journal: Molecular medicine (Cambridge, Mass.)

Published: November 29, 2021

Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.

Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer.

Journal: Biomedicines

Published: March 12, 2021

Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of GCM2, ITPRIPL1 and CCDC181 for Detection of Early Breast Cancer and Surgical Treatment Response.

Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of GCM2, ITPRIPL1 and CCDC181 for Detection of Early Breast Cancer and Surgical Treatment Response.

Journal: Cancers

Published: January 27, 2021

SMAD3 Hypomethylation as a Biomarker for Early Prediction of Colorectal Cancer.

SMAD3 Hypomethylation as a Biomarker for Early Prediction of Colorectal Cancer.

Journal: International journal of molecular sciences

Published: August 23, 2020

Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.

Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.

Journal: Clinical epigenetics

Published: November 12, 2019

Polysaccharides obtained from mycelia of Cordyceps militaris attenuated doxorubicin-induced cytotoxic effects in chemotherapy.

Polysaccharides obtained from mycelia of Cordyceps militaris attenuated doxorubicin-induced cytotoxic effects in chemotherapy.

Journal: African health sciences

Published: October 28, 2019

Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.

Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.

Journal: International journal of molecular sciences

Published: August 06, 2018

Bioactive Constituents from the Termite Nest-Derived Medicinal Fungus Xylaria nigripes.

Bioactive Constituents from the Termite Nest-Derived Medicinal Fungus Xylaria nigripes.

Journal: Journal of natural products

Published: January 06, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026